CellType

CellType YC Application

Winter 2026Active

CellType went through Y Combinator in the Winter 2026 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch
Winter 2026
Industry
HealthcareDrug Discovery and Delivery
Team size
2
Status
Active
Launched
2026

Founders

  • David van Dijk
    David van DijkCo-Founder & CEO
  • Ivan Vrkic
    Ivan VrkicCo-Founder

What CellType does

CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.

CellType's YC application, reconstructed

Y Combinator application

CellType, Winter 2026 batch. The real form questions, answered from public data.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

CellType

Describe what your company does in 50 characters or less.

The agentic drug company. We simulate human biology.

What is your company going to make? Please describe your product and what it does or will do.

We are building AI agents that run the entire drug discovery pipeline on top of biological foundation models that simulate human biology. Our platform can predict how drugs interact with biological systems, enabling us to discover new treatments faster and more reliably than traditional methods. We've already found and validated a new cancer treatment signal using this tech.

Where do you live now, and where would the company be based after YC?

We live and work in New York City, and after YC, CellType will remain based here.

Explain your decision regarding location.

New York City has the biotech ecosystem and pharma partners we need close by. We can recruit scientists and engineers here and maintain strong relationships with top pharma companies already collaborating with us.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

Frequently Asked Questions

Is this the real CellType YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from CellType's public data (launch notes, founder backgrounds, product description). It shows how a company like CellType would present itself to YC, not the text they submitted.

What YC batch was CellType in?

CellType was part of the Y Combinator Winter 2026 batch.

Who founded CellType?

CellType was founded by David van Dijk, Ivan Vrkic.

What does CellType do?

The agentic drug company. We simulate human biology.

How do I read the full reconstructed application?

Create a free Round Funded account. The full 26-answer version of CellType's application, and every other YC batch, is in YC Insights.

More YC startups like CellType